These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 22318091)
1. Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening. Wang H; Jia TH; Zacharias N; Gong W; Du HX; Wooley PH; Yang SY Gene Ther; 2013 Feb; 20(2):128-35. PubMed ID: 22318091 [TBL] [Abstract][Full Text] [Related]
2. The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure. Zhang T; Yu H; Gong W; Zhang L; Jia T; Wooley PH; Yang SY Biomaterials; 2009 Oct; 30(30):6102-8. PubMed ID: 19665222 [TBL] [Abstract][Full Text] [Related]
3. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. Ulrich-Vinther M; Carmody EE; Goater JJ; S balle K; O'Keefe RJ; Schwarz EM J Bone Joint Surg Am; 2002 Aug; 84(8):1405-12. PubMed ID: 12177271 [TBL] [Abstract][Full Text] [Related]
4. Cell-based osteoprotegerin therapy for debris-induced aseptic prosthetic loosening on a murine model. Zhang L; Jia TH; Chong AC; Bai L; Yu H; Gong W; Wooley PH; Yang SY Gene Ther; 2010 Oct; 17(10):1262-9. PubMed ID: 20428210 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling. Ping Z; Wang Z; Shi J; Wang L; Guo X; Zhou W; Hu X; Wu X; Liu Y; Zhang W; Yang H; Xu Y; Gu Y; Geng D Acta Biomater; 2017 Oct; 62():362-371. PubMed ID: 28867647 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. Goater JJ; O'Keefe RJ; Rosier RN; Puzas JE; Schwarz EM J Orthop Res; 2002 Mar; 20(2):169-73. PubMed ID: 11918293 [TBL] [Abstract][Full Text] [Related]
7. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway. Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465 [TBL] [Abstract][Full Text] [Related]
8. Effect of Interleukin 1 Receptor Antagonist Gene on Stable Expression Bone Marrow Mesenchymal Stem Cells and Early Aseptic Loosening of Hip Prosthesis of Mouse. Wang Y; Li G; Ma J; Ji B; Aishajiang A; Yelborati B; Cao L Mol Biotechnol; 2021 Mar; 63(3):232-239. PubMed ID: 33464542 [TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model. Yang SY; Mayton L; Wu B; Goater JJ; Schwarz EM; Wooley PH Arthritis Rheum; 2002 Sep; 46(9):2514-23. PubMed ID: 12355500 [TBL] [Abstract][Full Text] [Related]
10. Particulate and ion forms of cobalt-chromium challenged preosteoblasts promote osteoclastogenesis and osteolysis in a murine model of prosthesis failure. Yang S; Zhang K; Jiang J; James B; Yang SY J Biomed Mater Res A; 2019 Jan; 107(1):187-194. PubMed ID: 30358096 [TBL] [Abstract][Full Text] [Related]
11. Murine model of prosthesis failure for the long-term study of aseptic loosening. Yang SY; Yu H; Gong W; Wu B; Mayton L; Costello R; Wooley PH J Orthop Res; 2007 May; 25(5):603-11. PubMed ID: 17278141 [TBL] [Abstract][Full Text] [Related]
12. Strontium ranelate reduces the progression of titanium particle-induced osteolysis by increasing the ratio of osteoprotegerin to receptor activator of nuclear factor-κB ligand in vivo. Geng T; Sun S; Chen X; Wang B; Guo H; Zhang S; Jin Q Mol Med Rep; 2018 Mar; 17(3):3829-3836. PubMed ID: 29257329 [TBL] [Abstract][Full Text] [Related]
13. Lentivirus-mediated TNF-α gene silencing and overexpression of osteoprotegerin inhibit titanium particle-induced inflammatory response and osteoclastogenesis in vitro. Peng L; Wang H; Song K; Wang H; Liu P Mol Med Rep; 2016 Jan; 13(1):1010-8. PubMed ID: 26648171 [TBL] [Abstract][Full Text] [Related]
14. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626 [TBL] [Abstract][Full Text] [Related]
16. Cepharanthine ameliorates titanium particle-induced osteolysis by inhibiting osteoclastogenesis and modulating OPG/RANKL ratio in a murine model. Liao L; Lin Y; Liu Q; Zhang Z; Hong Y; Ni J; Yu S; Zhong Y Biochem Biophys Res Commun; 2019 Sep; 517(3):407-412. PubMed ID: 31376931 [TBL] [Abstract][Full Text] [Related]
17. Distinct gene expression of receptor activator of nuclear factor-kappaB and rank ligand in the inflammatory response to variant morphologies of UHMWPE particles. Ren W; Yang SY; Fang HW; Hsu S; Wooley PH Biomaterials; 2003 Nov; 24(26):4819-26. PubMed ID: 14530078 [TBL] [Abstract][Full Text] [Related]
18. The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Koreny T; Tunyogi-Csapó M; Gál I; Vermes C; Jacobs JJ; Glant TT Arthritis Rheum; 2006 Oct; 54(10):3221-32. PubMed ID: 17009257 [TBL] [Abstract][Full Text] [Related]
19. The Recombinant Protein EphB4-Fc Changes the Ti Particle-Mediated Imbalance of OPG/RANKL via EphrinB2/EphB4 Signaling Pathway and Inhibits the Release of Proinflammatory Factors In Vivo. Ge YW; Feng K; Liu XL; Chen HF; Sun ZY; Wang CF; Liu ZQ; Wang HW; Zhang JW; Yu DG; Mao YQ Oxid Med Cell Longev; 2020; 2020():1404915. PubMed ID: 32587656 [TBL] [Abstract][Full Text] [Related]
20. Scutellarin inhibits RANKL-mediated osteoclastogenesis and titanium particle-induced osteolysis via suppression of NF-κB and MAPK signaling pathway. Zhao S; Sun Y; Li X; Wang J; Yan L; Zhang Z; Wang D; Dai J; He J; Wang S Int Immunopharmacol; 2016 Nov; 40():458-465. PubMed ID: 27728897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]